@lectorfarma Er zit veel tussen de oren of aangeprate vooroordelen. https://t.co/aAhGCf381g .
@LucienHordijk @lectorfarma Kom op jongens, er zijn bakken bewijs voor gelijke werkzaamheid van generieke producten, en er is een overweldigende literatuur over nocebo-effecten https://t.co/aAhGCf381g
RT @joseluis_pa: we propose three key strategies to mitigate the nocebo effect in clinical when switching patients from reference biologic…
RT @gedefo_sefh: "Non-pharmacological Effects in Switching Medication: The Nocebo Effect in Switching from Originator to Biosimilar Agent."…
RT @gedefo_sefh: "Non-pharmacological Effects in Switching Medication: The Nocebo Effect in Switching from Originator to Biosimilar Agent."…
we propose three key strategies to mitigate the nocebo effect in clinical when switching patients from reference biologic to biosimilar: positive framing, increasing patient and healthcare professionals' understanding of biosimilars and utilising a managed
RT @gedefo_sefh: "Non-pharmacological Effects in Switching Medication: The Nocebo Effect in Switching from Originator to Biosimilar Agent."…
RT @gedefo_sefh: "Non-pharmacological Effects in Switching Medication: The Nocebo Effect in Switching from Originator to Biosimilar Agent."…
RT @gedefo_sefh: "Non-pharmacological Effects in Switching Medication: The Nocebo Effect in Switching from Originator to Biosimilar Agent."…
RT @gedefo_sefh: "Non-pharmacological Effects in Switching Medication: The Nocebo Effect in Switching from Originator to Biosimilar Agent."…
"Non-pharmacological Effects in Switching Medication: The Nocebo Effect in Switching from Originator to Biosimilar Agent." https://t.co/gB9aVPNJpZ